BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH – Get Free Report) was the target of a significant decline in short interest during the month of August. As of August 14th, there was short interest totaling 83 shares, a decline of 91.7% from the July 30th total of 1,000 shares. Based on an average daily trading volume, of 14,615 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short.
BioForce Nanosciences Trading Down 20.6%
OTCMKTS BFNH opened at $3.09 on Thursday. BioForce Nanosciences has a 1 year low of $0.18 and a 1 year high of $4.20. The company has a fifty day simple moving average of $2.08 and a 200 day simple moving average of $1.18. The company has a market cap of $103.67 million, a P/E ratio of 309.31 and a beta of -0.52.
BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) last released its earnings results on Monday, August 10th. The company reported $0.01 earnings per share for the quarter.
BioForce Nanosciences Company Profile
BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.
The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.
Recommended Stories
- Five stocks we like better than BioForce Nanosciences
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
